MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

New AI-Based Medical Image Segmentation and Measurement Tool Minimizes Human Errors in Clinical Analysis

By MedImaging International staff writers
Posted on 21 Jan 2021
Print article
Image: New AI-Based Medical Image Segmentation and Measurement Tool Minimizes Human Errors in Clinical Analysis (Photo courtesy of Business Wire)
Image: New AI-Based Medical Image Segmentation and Measurement Tool Minimizes Human Errors in Clinical Analysis (Photo courtesy of Business Wire)
A new general purpose, AI-based medical image segmentation and measurement tool for detecting objects of interest and their boundaries quickly and automatically could make surgical and diagnostic measurements easier and more accurate for better treatment decisions.

RSIP Vision (Jerusalem, Israel) has launched the AI-based solution that requires minimal work by the user to deliver an accurate 3D visualization and analysis of patient anatomy and is applicable across medical imaging verticals & modalities. The solution runs automatically and is robust and clinically accurate, avoiding human factors such as fatigue and misreads which may result in mistakes in measurement.

RSIP Vision is offering the AI-based software to medical device manufacturers for use in leading facilities worldwide in order to detect and localize the area of interest and use those complex features in a scan through a series of algorithms. The segmentation creates boundaries around the image for better viewing and performs automatic measurements. Physicians and researchers can receive consistent, repeatable measurements regarding the dimensions and characteristics of a specific area, using AI technology that is available across all modalities, including X-ray, CT scans, MR, surgical robotics, and pathology. For example, the tool can be used for one-click segmentation of lesions in multiple organs such as the lungs and the liver, across patient populations and cohorts. The new AI module can be easily integrated in medical device software for multiple applications, without the need to collect and train machine learning models on extensive domain-specific training data, accelerating time to market for medical device companies looking to stay ahead of the AI adoption curve.

“Distinguishing and measuring organs, lesions, and other areas of interest in biopsy and pre-surgical planning can be tedious work, which is generally assigned to a specific employee or technician, or even a physician,” said Ron Soferman, Founder & CEO at RSIP Vision. “Our new segmentation tool makes it easier to pinpoint specific points and boundaries in images, which in turn leads to greater accuracy during surgeries without being dependent on the capability and experience of a specific individual. In 2021, RSIP Vision will continue to drive innovation in image analysis across the medical verticals through custom software, advanced algorithm development and custom technologies which will be found in medical devices in leading facilities worldwide. RSIP Vision ensures customers can leverage the latest advances in AI and computer vision, in order to save time and cost during medical procedures.”

Related Links:
RSIP Vision

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Enterprise Imaging & Reporting Solution
Syngo Carbon
New
Illuminator
Trimline Basic
Ultrasound Software
UltraExtend NX

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more